Literature DB >> 23721713

Oocyte efficiency: does live birth rate differ when analyzing cryopreserved and fresh oocytes on a per-oocyte basis?

Kara N Goldman1, Nicole L Noyes, Jaime M Knopman, Caroline McCaffrey, James A Grifo.   

Abstract

OBJECTIVE: To compare the efficiency of oocyte cryopreservation (OC) and IVF using the metric "live births per mature oocyte retrieved."
DESIGN: Retrospective analysis.
SETTING: University-based fertility center. PATIENT(S): Forty women who underwent OC with thaw attempt between 2004 and 2010; 25 autologous and 15 donor-oocyte treatments were included. One thousand nine hundred eight women underwent their first, fresh conventional IVF treatment between 2004 and 2010; 1,392 used autologous oocytes, and 516 used donor oocytes. Autologous and donor-oocyte cycles were analyzed separately. All oocytes were obtained from women <age 40 years old. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Live-birth rate per mature oocyte retrieved (primary outcome), live-birth rate per ET, and blastocyst formation rate. RESULT(S): When OC/thaw cycles were compared with fresh IVF attempts, there was no significant difference in live-birth rate per mature oocyte retrieved (2.7% vs. 4.2%, respectively) or live-birth rate per ET (45.8% vs. 51.9%). Significantly more oocytes were harvested in the OC versus fresh IVF cycles (21 vs. 16); however, fewer blastocysts developed (3.9 vs. 6.3). Thus, we noted an age-independent approximate twofold decrease in blastocyst formation in the OC group. CONCLUSION(S): Our data suggest that while assisted reproductive technology remains an inefficient process, OC may be approaching fresh IVF when live birth is the primary consideration. However, OC may negatively impact the potential for blastocyst formation.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Oocyte cryopreservation; clinical efficiency; fertility preservation

Mesh:

Year:  2013        PMID: 23721713     DOI: 10.1016/j.fertnstert.2013.04.040

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth.

Authors:  Kate Devine; Sunni L Mumford; Kara N Goldman; Brooke Hodes-Wertz; Sarah Druckenmiller; Anthony M Propst; Nicole Noyes
Journal:  Fertil Steril       Date:  2015-03-23       Impact factor: 7.329

2.  Live birth in a 46 year old using autologous oocytes cryopreserved for a duration of 3 years: a case report documenting fertility preservation at an advanced reproductive age.

Authors:  Susan M Maxwell; Kara N Goldman; Patty A Labella; Caroline McCaffrey; Nicole L Noyes; James Grifo
Journal:  J Assist Reprod Genet       Date:  2014-03-08       Impact factor: 3.412

3.  Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.

Authors:  Sara Crawford; Sheree L Boulet; Jennifer F Kawwass; Denise J Jamieson; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2016-11-11       Impact factor: 7.329

4.  Oocyte cryopreservation beyond cancer: tools for ethical reflection.

Authors:  Alma Linkeviciute; Fedro A Peccatori; Virginia Sanchini; Giovanni Boniolo
Journal:  J Assist Reprod Genet       Date:  2015-07-03       Impact factor: 3.412

5.  Oncofertility: insights from IVF specialists-a worldwide web-based survey analysis.

Authors:  Gon Shoham; Rachel Levy-Toledano; Milton Leong; Ariel Weissman; Yuval Yaron; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2019-02-20       Impact factor: 3.412

Review 6.  Fertility preservation in reproductive age women with cancer.

Authors:  Peter Kovacs
Journal:  J Obstet Gynaecol India       Date:  2014-10-30

7.  The total pregnancy potential per oocyte aspiration after assisted reproduction-in how many cycles are biologically competent oocytes available?

Authors:  J G Lemmen; N M Rodríguez; L D Andreasen; A Loft; S Ziebe
Journal:  J Assist Reprod Genet       Date:  2016-04-06       Impact factor: 3.357

8.  The use of oocyte cryopreservation for fertility preservation in patients with sex chromosome disorders: a case series describing outcomes.

Authors:  Rachel A Martel; Jennifer K Blakemore; M Elizabeth Fino
Journal:  J Assist Reprod Genet       Date:  2022-03-23       Impact factor: 3.357

9.  Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study.

Authors:  Filippo Maria Ubaldi; Antonio Capalbo; Silvia Colamaria; Susanna Ferrero; Roberta Maggiulli; Gábor Vajta; Fabio Sapienza; Danilo Cimadomo; Maddalena Giuliani; Enrica Gravotta; Alberto Vaiarelli; Laura Rienzi
Journal:  Hum Reprod       Date:  2015-07-05       Impact factor: 6.918

Review 10.  Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer.

Authors:  Ana Milena Angarita; Cynae A Johnson; Amanda Nickles Fader; Mindy S Christianson
Journal:  Front Oncol       Date:  2016-04-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.